Friday, September 7, 2018
This Week’s Diagnosis: It was a busy week in Washington, DC, as
lawmakers returned to a packed agenda. Below is a summary of the key health
care happenings this week:
Congress
·
Opioids:
Senate Action. The Senate is
inching closer to a bipartisan comprehensive opioids package that could see
floor action as early as next week. While the House passed H.R. 6 and a few
standalone opioid-related bills several months ago, progress has been slower in
the Senate. The Senate is making modifications to H.R. 6 by adding bills that
passed out of the Senate HELP, Judiciary and Finance Committees, and striking
the more controversial and expensive provisions from the package. If H.R. 6
comes to the Senate floor, expect no amendments, and for negotiations with the
House to continue.
·
340B
Unexpected Bipartisan, Bicameral Letter to HRSA. Last week, leaders of the four committees
with jurisdiction over the 340B program sent a letter to
the Health Resources and Services Administration (HRSA) encouraging the agency
to utilize existing authority to issue guidance on several outstanding issues.
The letter, a rare display of bipartisan, bicameral agreement on 340B, shows
policymakers’ continued interest in 340B. It also may be a sign that there is
little appetite for legislative action on 340B in the coming months.
Specifically, the letter focuses on administrative dispute resolution, civil
monetary penalties against manufacturers and calculation of 340B ceiling prices.
·
Kavanaugh
Confirmation Hearing. The Senate held
several days of hearings on Judge Brett Kavanaugh, President Trump’s nominee to
fill the vacant seat on the Supreme Court of the United States. At the hearing,
Kavanaugh faced tough questions from Democrats about the Mueller investigation,
the future of the Affordable Care Act and the future of Roe v. Wade.
Protesters interrupted the hearing multiple times. Despite the dramatic and
contentious nature of the hearings, it is likely that Kavanaugh will be confirmed.
·
E&C
Health Subcommittee Approves Health Bills. The following bills passed out of the Energy and Commerce
Health Subcommittee and are expected to be considered by the full Committee in
the coming weeks:
o
Advancing Care for
Exceptional Kids Act, which provides enhanced federal matching for
certain care coordination services in Medicaid;
o
A bill to
clarify the authority of state Medicaid Fraud and Abuse Control Units;
o
A bill to
extend the Money Follows the Person demonstration in Medicaid for five years;
o
A discussion draft to
prohibit “gag clauses” in Medicare and private health insurance plans;
o
A discussion draft to
codify the CMS-operated Healthcare Fraud Prevention Partnership;
o
A discussion draft to
provide MedPAC with access to certain drug rebate information.
·
W&M
Passes Health Bills. The following
bills passed out the Ways and Means Committee and work is expected to continue
before bringing to the House floor:
o
H.R. 6662,
Empowering Seniors’ Enrollment Decision Act of 2018, allowing non-deemed
Medicare Cost Plan enrollees to take advantage of the special enrollment period
offered to deemed Medicare Cost Plan enrollees;
o
H.R. 6690,
Fighting Fraud to Protect Care for Seniors Act of 2018, establishing a
three-year pilot program to test the use of new technologies to strengthen
Medicare program integrity;
o
H.R. 6561,
Comprehensive Care for Seniors Act of 2018, directing the Secretary of HHS to
finalize proposed Program of All-Inclusive Care for the Elderly (PACE) regulations;
o
H.R. 3635,
Local Coverage Determination Clarification Act of 2017, improving the process
through which Medicare Administrative Contractors make local coverage
determinations, such as by requiring MACs to publicly post proposed LCDs
online.
Advisory Committees
·
MedPAC
September Meeting. The Medicare
Payment Advisory Commission (MedPAC) met this week on a variety of topics,
including redesigning Medicare’s hospital quality and value programs,
beneficiary enrollment in Medicare, aligning requirements for post-acute care;
a mandated report on long-term care hospitals; and a required report on
clinician payment. MedPAC is an advisory body that makes recommendations to
Congress. The meeting materials, including slide presentations, are
available here.
·
PTAC
Discussion of Payment Models. The Physician Focused Payment Model Technical Advisory
Committee (PTAC) met to deliberate and
vote on three models: acute unscheduled care model (AUCM),
innovative model for primary care office payment, and an APM for improved
quality and cost in providing home hemodialysis to geriatric patients residing
in skilled nursing facilities. PTAC recommended the AUCM model to the U.S.
Department of Health and Human Services (HHS) for implementation. PTAC was
created by the Medicare Access and CHIP Reauthorization Act to review and
recommend additional alternative payment models for HHS to test. HHS is not
required to test the models PTAC recommends, and so far the agency has declined
to adopt any of the PTAC recommended models. HHS Secretary Alex Azar and CMS
Administrator Seema Verma provided remarks at the meeting, praising the
valuable input PTAC provides as the agency develops new models.
Next Week’s Dose
·
The Senate and House
appropriators continue to plow through negotiations on the budget. Expect some
committee and floor action in the coming weeks. Shutdown watch has begun, since
the money stops flowing on September 30 and legislative days are very limited.
© 2018 McDermott Will & Emery
https://www.natlawreview.com/article/health-care-updates-mcdermottplus-check-september-7-2018
No comments:
Post a Comment